The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most disappointment comes from skipping it.
What I would want from a home test that does not exist yet — what changed since posts 91–112
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes obvious sources of bias.
This is the sort of thing that ought to be settled and apparently is not.
Coming back to post #91, because the follow-up matters more than the original answer.
Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96 from 98 per cent requires instrumentation and calibration that a kit does not have.
Correct me on the arithmetic if it is wrong; I would rather know.
Post #91 is right about the mechanism and I think understates the practical bit.
A test that gives a yes or no on the presence of peptide bonds is answering a genuinely useful question if that is the question you had. It is not a purity assay and cannot be read as one.
I would call that likely rather than established.
Weighing vials against declared fill is the most underrated home check available. It needs a balance with adequate resolution and it catches fill problems that no certificate would show.
Second this, and I would have said it less carefully.
Post #95 answers the question as asked. The question underneath it is different.
A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide.
I would be glad to be shown a cleaner way of putting this.
Post #95 describes the usual case. This is about the unusual one.
Photographs of test results posted here are worth including with the lighting and the timing stated, because both change the apparent result of a colorimetric method substantially.
Old habit: I write down the expected answer before I calculate it.
Adding the measurement that post #99 says would settle it.
A control sample of known material run alongside is what turns a home test from an impression into a comparison. Without one you are calibrating against memory.
Worth separating two things that post #99 runs together.
Nothing available at home distinguishes a correct sequence from a closely related incorrect one. That gap is fundamental rather than a matter of kit quality.
The general case is well covered; this is the awkward specific one.
This follows post #99 rather than contradicting it.
Where a home observation and an independent result disagree, the independent one is measuring something more specific. That does not make the home observation useless — it makes it a different measurement.
Collapsed as off-topic by two members at trust level 3 or above
Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which yours is comes first.
Thank you for taking the time. That was more work than a reply usually is.
Research-use-only material is not certified for anything by anybody, and no home procedure changes that. What home checks buy you is early detection of the obvious problems.
The honest answer is that it depends, and here is what it depends on.
Taking post #105 at face value and following it one step further.
The most useful home practice is not a test at all: photograph the vial, the cake, the label and the document on arrival. It costs nothing and it is the evidence you will wish you had.
I have seen it go both ways, which is why I hedge.
Everything in post #105 holds. The case it does not cover is the one I have.
Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively.
The honest cost comparison is a home kit against a single independent submission. For most people the second answers the question and the first answers a different, smaller one.
Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide and other structurally similar compounds. The test result conflates them.
Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative work.
This topic was referenced in
- Reading a home test result without over-claimingAnalytics › Home & field testing · 137 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Cost versus information: making the trade-off explicitly
Cost versus information: making the trade-off explicitly Writing it up because I had to work it out twice and would rather nobody else did. Asking about cost versus information directly, because I have read…
|
+2 | 6 | 12k | 11h |
|
Revisiting: Can a home kit substitute for a laboratory report? A careful no
Revisiting: Can a home kit substitute for a laboratory report? A careful no — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with the settled view on…
|
+50 | 56 | 9.8k | 1d |
|
A comparison of home results against a laboratory result on the same vial — does this still hold?
A comparison of home results against a laboratory result on the same vial — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Comparison of home…
|
+2 | 6 | 15k | 11h |
|
What consumer-accessible tests can and cannot determine
What consumer-accessible tests can and cannot determine — that is the question, and I have not found it answered plainly anywhere I have looked. Something about consumer-accessible tests does not reconcile…
|
2 | 17k | 1h | |
|
What consumer-accessible tests can and cannot determine — a second dataset
What consumer-accessible tests can and cannot determine — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Posting a small dataset on…
|
+117 | 131 | 45k | 10h |
Related topics — sharing the tags third-party testing, LOD & LOQ, documentation quality
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
A comparison of home results against a laboratory result on the same vial
Posting this under the heading it deserves: A comparison of home results against a laboratory result on the same vial Everything below is what sits behind that. Comparison of home results against: setting out…
|
+61 | 65 | 35k | 8mo |
|
What a simple presence test is genuinely useful for — does this still hold?
What a simple presence test is genuinely useful for — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Trying to work out what would count as…
|
2 | 22k | 16mo | |
|
Counter-ion form: the field almost nobody reports — one year on
On the subject in the title: Counter-ion form: the field almost nobody reports — one year on Working notes rather than a conclusion. The question about Counter-ion form that I actually want answered is the…
|
+121 | 139 | 31k | 16mo |
|
What consumer-accessible tests can and cannot determine — a second dataset
What consumer-accessible tests can and cannot determine — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Posting a small dataset on…
|
+117 | 131 | 45k | 10h |
|
An inter-laboratory comparison on one lot, tabulated — what changed since
An inter-laboratory comparison on one lot, tabulated — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of inter-laboratory…
|
+24 | 28 | 3.3k | 7mo |